Ionis Pharmaceuticals

company

About

Ionis Pharmaceuticals specializes in the discovery and development of RNA-targeted drugs.

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
$201.25M
Industries
Biotechnology,Health Care,Medical,Pharmaceutical
Founded date
Jan 1, 1989
Number Of Employee
251 - 500
Operating Status
Active
Stock Symbol
nasdaq:IONS
Legal Name
Ionis Pharmaceuticals, Inc.
Also Known As
Isis Pharmaceuticals

Ionis Pharmaceuticals is a pharmaceutical company. It specializes in RNA-targeted drug discovery and development. Ionis has developed antisense technology, an efficient, broadly applicable drug discovery platform that can treat diseases where no other therapeutic approaches have proven effective.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$751.25M
Ionis Pharmaceuticals has raised a total of $751.25M in funding over 2 rounds. Their latest funding was raised on Apr 8, 2021 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 8, 2021 Post-IPO Debt $550M Detail
Aug 27, 2012 Post-IPO Debt $201.25M Detail
May 24, 1991 IPO Detail

Investments

Number of Investments
Number of Lead Investments
4
3
Ionis Pharmaceuticals has made 4 investments. Their most recent investment was on Nov 14, 2022, when Metagenomi raised $80M.
Date Company Name
Round Money Raised Industry Lead Investor
Nov 14, 2022 Metagenomi
Corporate Round $80M Artificial Intelligence Yes
Series A $88M Biotechnology
Jan 9, 2020 Empirico
Series A $17M Biotechnology Yes
Seed $6.80M Biotechnology Yes

Employee Profiles

Number of Employee Profiles
38
Ionis Pharmaceuticals has 38 current employee profiles, including Employee Michael Tanowitz
Employee
Executive
Employee
Executive
Executive

Acquisition

Ionis Pharmaceuticals has acquired 1 organizations. Their most recent acquisition was Akcea Therapeutics on Aug 31, 2020. They acquired Akcea Therapeutics for $500M.

Date Company Name
Industry Acquisition Type Price
Biotechnology acquisition $ 500M Detail